Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 2 | Mind Blowing Facts

Belgian drugmaker UCB to invest $2B in suburban Atlanta plant, adding 330 jobs

Belgian pharmaceutical maker UCB says it will build a $2 billion drug manufacturing plant near Atlanta

The Independent UK

Five Plead Guilty in $14.6M Fraud Diverting Funds Intended for Child Nutrition Funds

Five defendants plead guilty in the $14.6M Feeding Our Future fraud, exposing one of the largest pandemic scams targeting child nutrition funds.

International Business Times UK

Phizzle: Reframing Pharma Manufacturing Through Digitized Workflows to Strengthen Data Integrity and Operational Efficiency

Healthcare costs have surpassed $5 trillion in the United States and are increasing at approximately 8% annually, reinforcing the need for more streamlined and reliable systems that can support both compliance and performance.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Recalls 90,000 Children's Ibuprofen Bottles Nationwide After Consumers Report Black Particles, Gel Mass

FDA Class II recall: Nearly 90,000 bottles of children's ibuprofen by Strides Pharma contaminated with black particles. Check lot numbers 7261973A and 7261974A to ensure safety. Learn about potential health risks and next steps.

International Business Times UK

AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress

Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy trading volume exceeding 183 million shares as investors reacted to a key patent milestone and ongoing clinical advancements in its lead drug Ampligen for pancreatic cancer.

International Business Times

Your Mounjaro Knockoff Could Kill You

Boston Medical Group last year warned that purchasing Ozempic and other weight-loss drugs from unauthorized sellers is risky business, as their products can be fake or of poor quality. The FDA had already shut down more than 250 fake websites for selling counterfeit weight loss drugs or other medications.

International Business Times

Pharma Executives Sentenced to Decades for $92M Black‑Market HIV Drug Scheme

Pharma executives sentenced to decades in prison after a $92M black-market HIV drug scheme exposed illegal buybacks, unsafe resale practices, and fraud.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Ozempic Controversy Deepens as FDA Accuses Novo Nordisk of Failing to Report Patient Deaths, One Linked To Suicide

Novo Nordisk faces FDA scrutiny for failing to report Ozempic-linked deaths, highlighting systemic issues in safety reporting. Learn about the implications for patient safety and ongoing legal challenges.

International Business Times UK

One of Britain’s last major chemical plants at risk as energy prices surge

If costs stay high for the next three months, US owner Peter Huntsman says he will close the site on Teesside

The Guardian - UK

Illegal weight loss jabs being sold in London pubs and fish and chip shops, report claims

It is alleged beauticians and personal trainers are exploiting soaring interest in weight loss jabs

Evening Standard

Feds warn Ozempic and Wegovy maker over failure to report side-effects from weight-loss drugs

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences

The Independent UK

Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds

The Guardian - UK

Novo Nordisk drops lawsuit over weight loss medications, enters collaboration with online pharmacy

The news sent shares of Hims & Hers Health Inc. soaring by more than 40% in Monday morning trading

The Independent UK

Former GlaxoSmithKline HQ in west London to be transformed into 1,500 new homes

Ambitious plans to redevelop the former headquarters of GlaxoSmithKline in Brentford have been given the green light

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Trump administration’s embattled FDA vaccine chief departing for the second time

Vinay Prasad to leave in April after decisions involving vaccine reviews and specialty drugs for rare diseases

The Times of India

Navjot, Attarvir, Balwinder and Manpreet Singh charged after $2.3 million in suspected fentanyl seized in Brampton

Police have charged four men and seized more than $2.3 million worth of suspected fentanyl as part of a major drug trafficking investigation that stretched from the Greater Toronto Area to Alberta.

The Guardian - UK

Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss

Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise

The Independent UK

CVS warns it could close all 134 locations in a single state if new bill goes ahead

A spokesperson for CVS Health slammed the proposal, branding it ‘bad for Tennessee’

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine

The Independent UK

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

The Times of India

UAE urgently recalls 4 health products: What every consumer must know

UAE health authorities have urgently recalled four products, including three supplements and one medical item, due to serious safety concerns like unapproved ingredients and contamination. Consumers are warned against purchasing or using these. The recall of the supplements and health product highlights the nation's commitment to public health and strict…

The Independent UK

Novo Nordisk announces plan to cut Ozempic and Wegovy prices up to 50 percent

One in eight Americans are taking weight loss drugs like Ozempic and Wegovy

The Guardian - UK

AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects

The Times of India

UAE announces new pharmaceutical rule to break medicine monopolies and lower drug costs

UAE residents will find essential medicines more accessible and affordable following a landmark reform by the Emirates Drug Establishment. Effective February 24, 2026, a new rule mandates multiple authorized agents for each drug, dismantling single-agent monopolies. This move enhances supply chain flexibility, boosts competition, and strengthens the nation's healthcare sector.

Axios

The biggest challenge to Trump's drug price claims? Reality

It's unclear how many patients will actually pay less under Trump's "most favored nation" deals.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.